Cite
Issapour A, Frank B, Crook S, et al. Safety and tolerability of combination therapy with ambrisentan and tadalafil for the treatment of pulmonary arterial hypertension in children: Real-world experience. Pediatr Pulmonol. 2021;doi: 10.1002/ppul.25796.
Issapour, A., Frank, B., Crook, S., Hite, M. D., Dorn, M. L., Rosenzweig, E. B., Ivy, D. D., & Krishnan, U. S. (2021). Safety and tolerability of combination therapy with ambrisentan and tadalafil for the treatment of pulmonary arterial hypertension in children: Real-world experience. Pediatric pulmonology, . https://doi.org/10.1002/ppul.25796
Issapour, Azadeh, et al. "Safety and tolerability of combination therapy with ambrisentan and tadalafil for the treatment of pulmonary arterial hypertension in children: Real-world experience." Pediatric pulmonology vol. (2021). doi: https://doi.org/10.1002/ppul.25796
Issapour A, Frank B, Crook S, Hite MD, Dorn ML, Rosenzweig EB, Ivy DD, Krishnan US. Safety and tolerability of combination therapy with ambrisentan and tadalafil for the treatment of pulmonary arterial hypertension in children: Real-world experience. Pediatr Pulmonol. 2021 Dec 17; doi: 10.1002/ppul.25796. Epub 2021 Dec 17. PMID: 34921523.
Copy
Download .nbib